• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Lumexa Imaging Holdings Inc.

    4/28/26 4:37:06 PM ET
    $LMRI
    Medical Specialities
    Health Care
    Get the next $LMRI alert in real time by email
    DEFA14A 1 d148040ddefa14a.htm DEFA14A DEFA14A
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

     

     

    SCHEDULE 14A INFORMATION

    Proxy Statement Pursuant to Section 14(a) of the

    Securities Exchange Act of 1934

    (Amendment No. )

     

     

    Filed by the Registrant ☒      Filed by a Party other than the Registrant ☐

    Check the appropriate box:

     

    ☐

    Preliminary Proxy Statement

     

    ☐

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

    ☐

    Definitive Proxy Statement

     

    ☒

    Definitive Additional Materials

     

    ☐

    Soliciting Material Pursuant to § 240.14a-12

    Lumexa Imaging Holdings, Inc.

    (Name of Registrant as Specified in Its Charter)

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check the appropriate box):

     

    ☒

    No fee required.

     

    ☐

    Fee paid previously with preliminary materials.

     

    ☐

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     
     


    LOGO

    P.O. BOX 8016, CARY, NC 27512-9903 Your vote matters! Meeting Materials: Notice of Meeting and Proxy Statement & Annual Report or Form 10-K Important Notice Regarding the Availability of Proxy Materials for the Stockholder Lumexa Imaging Holdings, Inc. Meeting To Be Held On June 10, 2026 For Stockholders of record as of April 13, 2026 Annual Meeting of Stockholders To order paper materials, use one of the Wednesday, June 10, 2026 8:30 AM, Eastern Time Annual meeting to be held live via the internet—please visit www.proxydocs.com/LMRI for following methods. more details. You must register to attend the meeting online and/or participate at www.proxydocs.com/LMRI Internet: For a convenient way to view proxy materials, VOTE, and obtain www.investorelections.com/LMRI directions to attend the meeting go to www.proxydocs.com/LMRI To vote your proxy while visiting this site, you will need the 12 digit control number in the box below. Call: 1-866-648-8133 This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting. Email: [email protected] Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the * If requesting material by e-mail, please send a blank e-mail with the internet. 12 digit control number (located below) in the subject line. No other requests, instructions OR other inquiries should be included with your If you want to receive a paper or e-mail copy of the proxy material, you must request one. e-mail requesting material. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year’s meeting, you must make this request on or before May 29, 2026. Your control number Have the 12 digit control number located in the box above available when you access the website and follow the instructions. Copyright © 2026 BetaNXT, Inc. or its affiliates. All Rights Reserved


    LOGO

    Lumexa Imaging Holdings, Inc. Annual Meeting of Stockholders THE BOARD OF DIRECTORS RECOMMENDS A VOTE: FOR each of the director nominees in Proposal 1 FOR Proposal 2 PROPOSAL 1. To elect three Class I directors to the Board of Directors, each to serve until the Company’s 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal; 1.01 Lee Cooper 1.02 Brian Regan 1.03 Caitlin Zulla 2. To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026; and 3. To transact such other business as may properly come before the Annual Meeting or any postponement or adjournment thereof.

    Get the next $LMRI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LMRI

    DatePrice TargetRatingAnalyst
    2/9/2026$23.00Outperform → Strong Buy
    Raymond James
    1/5/2026$23.00Overweight
    Analyst
    1/5/2026$23.00Buy
    Jefferies
    1/5/2026$22.00Overweight
    Wells Fargo
    1/5/2026Outperform
    William Blair
    1/5/2026$23.00Outperform
    Raymond James
    1/5/2026$23.00Outperform
    Leerink Partners
    1/5/2026$22.00Buy
    Deutsche Bank
    More analyst ratings

    $LMRI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date

    RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its first quarter 2026 financial and operational results after market close on Tuesday, May 12, 2026. The Company will host a conference call and live webcast to discuss the results at 5:00 p.m. ET. The live audio webcast will be available in the Investor Relations section of the Company's website at ir.lumexaimaging.com. A replay of the webcast will be available for approximately one year. About Lumexa Imaging Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team member

    4/28/26 4:15:00 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

    RALEIGH, N.C., April 20, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the appointment of Kyle Lynch as its new Chief Growth Officer (CGO). Lynch joins the executive leadership team to lead the company's enterprise growth strategy, with responsibility for expanding Lumexa Imaging's platform through joint ventures, acquisitions, and de novo development. In this role, Lynch will oversee the full growth lifecycle, including opportunity origination, transaction execution, and post-close value realization, with a focus on driving sustainable, profitable growth and maximizing return on invested capita

    4/20/26 7:00:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance

    RALEIGH, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced certain financial results for the fourth quarter ended December 31, 2025, and reiterated full year 2026 guidance. The financial results included in this release pertaining to the fourth quarter and full year 2025 are preliminary, unaudited, and subject to final review and adjustment. "The fourth quarter of 2025 marked a strong close to an important year for Lumexa Imaging, with continued momentum across the business," said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. "Strong Adjusted EBITDA growth was driven by a

    3/26/26 6:00:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Principal Accounting Officer Walker James Edward Jr. was granted 12,414 shares, increasing direct ownership by 252% to 17,346 units (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    2/27/26 5:40:01 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Chief Financial Officer Martin James Anthony was granted 54,054 shares (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    1/15/26 12:51:17 PM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form 3 filed by new insider Martin James Anthony

    3 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    1/15/26 12:49:28 PM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    SEC Filings

    View All

    SEC Form DEFA14A filed by Lumexa Imaging Holdings Inc.

    DEFA14A - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    4/28/26 4:37:06 PM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form DEF 14A filed by Lumexa Imaging Holdings Inc.

    DEF 14A - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    4/28/26 4:36:16 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    4/9/26 5:11:27 PM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lumexa Imaging Holdings upgraded by Raymond James with a new price target

    Raymond James upgraded Lumexa Imaging Holdings from Outperform to Strong Buy and set a new price target of $23.00

    2/9/26 8:16:45 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Analyst initiated coverage on Lumexa Imaging Holdings with a new price target

    Analyst initiated coverage of Lumexa Imaging Holdings with a rating of Overweight and set a new price target of $23.00

    1/5/26 9:16:52 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Jefferies initiated coverage on Lumexa Imaging Holdings with a new price target

    Jefferies initiated coverage of Lumexa Imaging Holdings with a rating of Buy and set a new price target of $23.00

    1/5/26 8:58:21 AM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Leadership Updates

    Live Leadership Updates

    View All

    Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

    RALEIGH, N.C., April 20, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the appointment of Kyle Lynch as its new Chief Growth Officer (CGO). Lynch joins the executive leadership team to lead the company's enterprise growth strategy, with responsibility for expanding Lumexa Imaging's platform through joint ventures, acquisitions, and de novo development. In this role, Lynch will oversee the full growth lifecycle, including opportunity origination, transaction execution, and post-close value realization, with a focus on driving sustainable, profitable growth and maximizing return on invested capita

    4/20/26 7:00:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Middleby Appoints Glenn Eisenberg To Board of Directors

    The Middleby Corporation (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members. "We are pleased to welcome Glenn Eisenberg to the Middleby Board. His deep experience will be an immediate asset as we execute our strategic transformation," said Tim FitzGerald, Middleby CEO. "Glenn has a proven 20-year track record of success as a public company CFO and senior operating executive across complex global manufacturing businesses. His expertise in financial discipline, industrial manufacturing, capital allocation,

    3/6/26 7:00:00 AM ET
    $LH
    $LMRI
    $MIDD
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials

    $LMRI
    Financials

    Live finance-specific insights

    View All

    Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date

    RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its first quarter 2026 financial and operational results after market close on Tuesday, May 12, 2026. The Company will host a conference call and live webcast to discuss the results at 5:00 p.m. ET. The live audio webcast will be available in the Investor Relations section of the Company's website at ir.lumexaimaging.com. A replay of the webcast will be available for approximately one year. About Lumexa Imaging Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team member

    4/28/26 4:15:00 PM ET
    $LMRI
    Medical Specialities
    Health Care